ITM Isotope Technologies Munich
Tracked across 1 events · 6 articles · First seen Sep 21, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Telix Pharmaceuticals agreed to acquire privately held ITM Isotope Technologies Munich in a deal valued at up to $2.35 billion, comprising $1.65 billion upfront plus up to $700 million in contingent milestone payments. The upfront…
Impact: Target being acquired at up to $2.35 billion, giving its shareholders about 23.7% of the combined company and access to Telix's commercial platform. Its profitable radioisotope business and ITM-11 pipeline are the core strategic assets.
Sep 21, 2026 · 6 articles
100
Telix Pharmaceuticals agreed to acquire ITM Isotope Technologies MunichTelix acquires ITM Isotope...
70
ITM Isotope Technologies Munich approved acquisition Telix PharmaceuticalsTelix acquires ITM Isotope...
65
United States — Food and Drug Administration rejected application ITM Isotope Technologies MunichTelix acquires ITM Isotope...
60
Telix Pharmaceuticals assumed net debt ITM Isotope Technologies MunichTelix acquires ITM Isotope...
55
Telix Pharmaceuticals approved transaction ITM Isotope Technologies MunichTelix acquires ITM Isotope...
ERGEN INTELLIGENCE
Track ITM Isotope Technologies Munich live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard